In the long human struggle against cancer, a new chapter is being written — not with chemicals that poison indiscriminately, but with a therapy that teaches the body's own defenses to recognize and destroy what does not belong. Fifteen patients with advanced, treatment-resistant head and neck cancers, having exhausted every conventional option, experienced complete tumor elimination after receiving amivantamab in an international trial. Presented at the American Society of Clinical Oncology in Chicago, the findings do not yet constitute a cure, but they represent something rarer and more fragi
InfoMoney
· May 30, 2026
· health
· 2 min de leitura
High
Apuração: Verificado
Experimental immunotherapy achieves complete tumor elimination in 15 advanced cancer patients
15 patients with previously untreatable advanced cancers experienced complete tumor elimination, with one patient regaining ability to eat and speak normally.
◉
Health & Medicine
2697 artigos relacionados
Ozempic and GLP-1 drugs: how the weight-loss revolution works and what…
O GLOBO · 99% correspondência
Eli Lilly's retatrutida shows 28% weight loss in trials, rivaling bari…
Poder360 · 90% correspondência
GLP-1 drugs like Ozempic expand beyond weight loss into Alzheimer's, h…
Folha de S.Paulo · 90% correspondência
Retatrutida achieves 30% weight loss in landmark obesity study
Veja Saúde · 90% correspondência
Anvisa aprova remdesivir contra covid-19 e registra vacina de Oxford
Jornal de Brasília · 90% correspondência
Cobertura Relacionada
Folha de S.Paulo · Aug 18
Cisne mantém reinado como melhor sal entre paulistanos pela quinta vez
A marca Cisne vence pela quinta vez consecutiva a pesquisa Datafolha como melhor sal entre paulistanos, com 50% das menç…
Folha de S.Paulo · Aug 18 Projeto Quebrada Alimentada é eleito iniciativa de destaque em gastronomia pela FolhaO projeto Quebrada Alimentada, nascido no restaurante Mocotó durante a pandemia, foi eleito iniciativa de destaque pela …
UOL · Aug 17 Lucy Ramos revela que Globo consultou obstetra para cena de acidente na novelaA atriz Lucy Ramos revelou que a Globo consultou seu obstetra antes de gravar uma cena de acidente fatal enquanto ela es…
Estadão · Aug 17 Asma não impede atividade física; exercício regular ajuda no controle da doençaPesquisas confirmam que atividade física beneficia asmáticos, mas requer controle da doença e atenção a fatores ambienta…
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
🌎
Medical breakthrough in cancer immunotherapy has no direct geopolitical implications; this is a clinical advancement with potential humanitarian benefits across nations.
Escalation Risk
low
Confidence
HIGH
No power dynamics shifts. This is a health/science matter with international collaboration (11 countries) that transcends geopolitical competition.
Lente Econômica
📈
Experimental immunotherapy (amivantamab) shows promising results eliminating tumors in advanced cancer patients, with potential to expand pharmaceutical market and reduce healthcare costs through improved treatment options.
Market Signal
bullish
Confidence
MED
Pharmaceutical and Biotechnology
Healthcare and Medical Services
Medical Devices and Diagnostics
Health Insurance
Hospital and Clinical Services
Patients with treatment-resistant advanced cancers gain access to potentially life-extending therapy, improving quality of life and survival rates. However, costs may be high initially, potentially affecting healthcare affordability until broader adoption and competition reduce prices.
Regulatory agencies (FDA, EMA, ANVISA in Brazil) will likely accelerate approval pathways for promising immunotherapies. Healthcare systems may need to adjust reimbursement policies and budget allocations for expensive cancer treatments. Patent and intellectual property considerations will influence market competition and drug pricing.